<DOC>
	<DOCNO>NCT00836927</DOCNO>
	<brief_summary>To describe long-term safety deforolimus patient clinical benefit establish prior parent trial deforolimus and/or remain long-term follow-up .</brief_summary>
	<brief_title>Extension Trial Deforolimus Patients With Advanced Cancer ( 8669-038 )</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>Patient must participate deforolimus parent trial Patients must derive clinical benefit parent trial Patient anticancer treatment ( ) unless therapy allow parent protocol ECOG performance status less equal 2 patient schedule receive treatment deforolimus ; requirement patient include followup purpose Patients childbearing potential must negative pregnancy test within 7 day prior screen must use approved contraceptive screen 30 day last dose study drug Signed inform consent Has participate parent trial Women receive study drug pregnant lactate Any condition Investigator 's judgment render patient unable fully understand provide inform consent and/or comply protocol</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>